Factors Influencing HPV Vaccine Hesitancy Among Adults in China
Overview
This study identifies key factors influencing HPV vaccine hesitancy among adults in China, revealing a 19.86% hesitancy rate. Significant predictors include higher complacency, lower confidence, and lower HPV knowledge.
Background
HPV vaccination is essential for preventing HPV-related diseases, yet hesitancy poses a significant barrier to achieving adequate vaccination coverage. In China, despite improved vaccine availability and policies, low vaccination rates indicate the need to understand the determinants of vaccine hesitancy among adults.
Data Highlights
Demographic
HPV Vaccine Hesitancy Rate
Overall
19.86%
Men
26.5%
Women
18.6%
Key Findings
The mean age of participants was 33.41 years, with 84.4% being women.
HPV vaccine hesitancy was found to be 19.86% overall.
Men exhibited a higher hesitancy rate (26.5%) compared to women (18.6%).
Higher complacency, lower confidence, and lower HPV knowledge were significant predictors of vaccine hesitancy.
Future interventions should focus on improving HPV knowledge, especially among men and older women.
Clinical Implications
Healthcare providers should prioritize educational initiatives to enhance HPV knowledge and address complacency among adults. Tailored interventions may be necessary to rebuild confidence in the HPV vaccine, particularly in demographics exhibiting higher hesitancy.
Conclusion
Addressing HPV vaccine hesitancy is critical for improving vaccination rates in China. Targeted strategies that enhance knowledge and confidence can help mitigate the factors contributing to hesitancy.
